Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas - Wei, Cheng; Wang, Bo; Peng, Dazhao; Zhang, Xiaoyang; Li, Zesheng; Luo, Lin; He, Yingjie; Liang, Hao; Du, Xuezhi; Li, Shenghui; Zhang, Shu; Zhang, Zhenyu; et al. (Frontiers in Immunology, 2022)